Clinical Observation of CABA System in the Treatment of End-stage Liver Disease With Inflammation

Clinical trial NCT05780190 · UNKNOWN

Trial details

NCT number: NCT05780190
Sponsor: Qin Ning
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

To Evaluate the Clinical Efficacy and Safety of the New ALSS

Start date: 2023-03-10
Primary completion: 2024-03-08
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.